Your Article Summary
Rx Scripts Spike in Wake of Swine Flu
PharmExec, 05/11/09
The milder than originally perceived H1N1 "swine flu" might have government officials and physicians pondering the depth of its impact, but one thing that is hard to ignore is the impact the illness has had on the pharmaceutical industry's new prescription figures.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09
US FDA approves SEROQUEL XR for add-on treatment of Major Depressive Disorder
AstraZeneca, 12/07/09
FDA Approves Initiation of Clinical Studies in the U.S. for T2000, Taros Proprietary Non-Sedating Barbiturate Compound
Taro Pharmaceuticals USA, 12/07/09
Article Search
Sponsor


See Latest Articles


